On a gorgeous October morning at Lincoln Financial Field, Children’s Hospital of Philadelphia’s (CHOP) 23rd Annual Buddy Walk & Family Fun Day took place benefiting the hospital’s Trisomy 21 (Down syndrome) Program, supporting healthier futures for patients and helping to improve the lives of individuals with Down syndrome. Over the past 22 years, the event has generated $4.6 million and this year, $365,000+ was raised, a record-breaking amount.

Researchers at Children’s Hospital of Philadelphia (CHOP) announced significant findings in the treatment of neuroblastoma, a cancer of the peripheral nervous system that usually occurs as a solid tumor in a child’s chest or abdomen. The study offers insights that could lead to new, personalized medicine approaches in immunotherapy treatment. The findings were published today in the journal Cancer Cell.

The findings show how more rapid results can improve practice and lead to more accurate and timely diagnoses

Alexis A. Thompson, MD, MPH, chief, Division of Hematology, and the Elias Schwartz MD Endowed Chair in Hematology at CHOP, has been recognized for her leadership in sickle cell disease (SCD) treatment and research.

Actors and actresses from this year’s original Hallmark holiday movies interacted with patients and their families through various holiday-themed stations.

Learn why whooping cough (pertussis) is making a comeback, what symptoms are, and how to protect your family.

Read this case study to learn how spinal surgery can help improve mobility for children with spastic diplegic cerebral palsy.

This case study discusses when primary care professionals should refer their patients to a specialist.

Researchers at Children’s Hospital of Philadelphia (CHOP) announced the results of a new study highlighting significant genetic links in speech and language disorders in children.

Researchers from Children’s Hospital of Philadelphia (CHOP) and Vanderbilt University Medical Center were awarded a $7.37 million RC2 grant from the National Institutes of Health (NIH) to lead a five-year multisite project across the U.S. focused on kidney stone disease research.